TECHNOLOGY LICENSING OPPORTUNITY: Plane-Wave Ultrasound Tomography for Cancer Imaging

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

TRIAD - DOE CONTRACTOR

Contract Value

Not provided

Codes & Classification
Solicitation Number

S-133625

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

New Mexico, UNITED STATES

SourceSAM
This special notice announces a technology licensing opportunity for the Plane-Wave Ultrasound Tomography platform, developed by Los Alamos National Laboratory (LANL) and offered through its Technology Partnerships program. The purpose of this procurement activity is to identify commercial partners interested in licensing a next-generation imaging technology designed to advance the detection and characterization of cancers, with a particular focus on prostate and breast cancer. The platform represents a significant leap forward in ultrasound imaging, addressing longstanding limitations in tissue characterization and image resolution that have constrained the effectiveness of conventional clinical ultrasound systems. The scope of the technology encompasses a comprehensive ultrasound toolkit, including advanced methods for ultrasound waveform tomography and inversion, efficiency improvements, and super-resolution imaging techniques. These innovations collectively enable the reconstruction of tissue properties from plane-wave ultrasound data, moving beyond traditional image formation to provide more quantitative and clinically useful information. Key technical features include wave-energy-based preconditioning, spatial and edge regularization, and super-resolution TR-MUSIC methods, all of which contribute to improved reconstruction speed, stability, and image quality. The intended outcomes of licensing this technology are to facilitate the commercialization and integration of these advanced imaging capabilities into medical and diagnostic imaging systems. The platform is particularly well-suited for applications in cancer screening, diagnosis, and treatment monitoring, with specific utility in prostate and breast cancer programs, women’s health, and urology. By enabling more accurate and robust tissue characterization, the technology aims to enhance diagnostic confidence, support early detection, and extend the value of ultrasound imaging in clinical practice. Key requirements and objectives for potential licensees include the ability to integrate and commercialize patented and patent-pending inventions, as covered by US Patent Nos. 9,955,943; 9,955,944; 10,028,728; 11,344,283; 10,034,656; 10,231,707; and 11,284,858. The technology is currently at Technology Readiness Level (TRL) 5, indicating that it has been validated in a relevant environment and is ready for further development and commercialization. LANL offers both exclusive and non-exclusive licensing agreements, making this opportunity accessible to established companies as well as start-ups seeking to enhance their product portfolios with cutting-edge imaging solutions. The contracting entity for this opportunity is TRIAD, a Department of Energy (DOE) contractor operating under the Office of the Department of Energy. The place of performance is New Mexico, United States. The relevant classification codes include NAICS Code 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing) and Product Service Code 6505. There are no set-aside requirements associated with this notice. Interested parties should note that this is not a solicitation for external development services, but rather an invitation to license and commercialize LANL’s patented technologies. The licensing program is designed to transition laboratory-developed inventions into commercial innovations, supporting the broader mission of the Department of Energy to foster technological advancement and market competitiveness. For further information or to initiate discussions regarding licensing, interested contractors are encouraged to contact Caleb Ledgerwood or Lindsay Augustyn at [email protected]. Additional details about the technology and the licensing process can be found at https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology and m.lanl.gov/tech-search. The official notice and any updates are available on SAM.gov under Opportunity ID 3c13b58906c34b889450a900d83360ca. This opportunity remains active, with a response deadline of January 6, 2026.